• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Ponatinib

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
PonatinibOncologyBCR-ABL T3151BCR –ABL T315I mutationIndications and Usage,
Adverse Reactions, Clinical Pharmacology,
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling